← Back to Search

Video Laryngoscope Group for Acute Respiratory Failure (DEVICE Trial)

N/A
Waitlist Available
Led By Matthew W Semler, MD, MSc
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from induction to 2 minutes following tracheal intubation
Awards & highlights

DEVICE Trial Summary

This trial will compare the rates of successful intubation on the first attempt between video and direct laryngoscopy in a large, diverse group of critically ill adults.

Eligible Conditions
  • Acute Respiratory Failure

DEVICE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of procedure (minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of procedure (minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of intubations with successful intubation on the first attempt
Secondary outcome measures
Severe complications of tracheal intubation
Other outcome measures
All-cause in-hospital mortality
Duration of laryngoscopy and tracheal intubation
Esophageal intubation
+8 more

DEVICE Trial Design

2Treatment groups
Active Control
Group I: Video Laryngoscope GroupActive Control1 Intervention
For patients assigned to the video laryngoscope group, the operator will use a video laryngoscope on the first laryngoscopy attempt. A video laryngoscope will be defined as a laryngoscope with a camera and a video screen. Trial protocol will not dictate the brand of video laryngoscope.
Group II: Direct Laryngoscope GroupActive Control1 Intervention
For patients assigned to the direct laryngoscope group, the operator will use a direct laryngoscope on the first laryngoscopy attempt. A direct laryngoscope will be defined as a laryngoscope without a camera or a video screen. Trial protocol will not dictate the brand of direct laryngoscope or the blade shape.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
670,772 Total Patients Enrolled
6 Trials studying Acute Respiratory Failure
8,345 Patients Enrolled for Acute Respiratory Failure
University of Colorado, DenverOTHER
1,732 Previous Clinical Trials
2,142,163 Total Patients Enrolled
2 Trials studying Acute Respiratory Failure
1,421 Patients Enrolled for Acute Respiratory Failure
Matthew W Semler, MD, MScPrincipal InvestigatorVanderbilt University Medical Center
6 Previous Clinical Trials
7,497 Total Patients Enrolled
3 Trials studying Acute Respiratory Failure
4,771 Patients Enrolled for Acute Respiratory Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations are actively involved in this trial's implementation?

"For this clinical trial, there are 12 sites that patients can access. These include Harborview Medical Center in Seattle, Ochsner Medical Center | Ochsner Health System in New Orleans, and Vanderbilt University Medical Center in Nashville, as well as 9 other facilities scattered around the United States."

Answered by AI

Are there any vacancies for the clinical trial that are available to applicants?

"Affirmative. Clinicaltrials.gov data conveys that this clinical trial, initially posted on March 7th 2022, is currently recruiting patients for participation. 2000 participants are sought from 12 distinct medical centres."

Answered by AI

How many participants have signed up for this research project?

"Affirmative. Evidenced by the online registry, clinicaltrials.gov, this medical trial commenced on March 7th 2022 and is currently welcoming patients to enroll in its study. In total, 2000 individuals are required from 12 different sites."

Answered by AI
~461 spots leftby Apr 2025